Flos puerariae extract prevents myocardial apoptosis via attenuation oxidative stress in streptozotocin-induced diabetic mice

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Yu, Wei ^a   Zha, Wenliang ^a   Guo, Shuang ^a   Cheng, Hongke ^a   Wu, Jiliang ^a   Liu, Chao ^a  

^a HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CASPASE 3; FLOS PUERARIAE EXTRACT; GLUCOSE; GLUTATHIONE PEROXIDASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STREPTOZOCIN; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ANTIOXIDANT; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOS PUERARIAE; GLUCOSE BLOOD LEVEL; HEART MUSCLE CELL; HEART PROTECTION; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; MOUSE; MYOFILAMENT; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PUERARIA; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CHEMISTRY; COMPLICATION; DIABETES COMPLICATIONS; DIABETIC CARDIOMYOPATHIES; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; NADPH OXIDASE; OXIDATIVE STRESS; PLANT EXTRACTS; PUERARIA; SUPEROXIDES;

EID: 84901399281     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098044     Document Type: Article

References (39)

1. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, et al. (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30: 595-602.
2. Litwin SE (2013) Diabetes and the heart: is there objective evidence of a human diabetic cardiomyopathy? Diabetes 62: 3329-3330.
3. Wang J, Wang H, Hao P, Xue L, Wei S, et al. (2011) Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats. Mol Med 17: 172-179.
4. Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY (2000) High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 101: 2618-2624. (Pubitemid 30350641)
5. Cai L, Wang Y, Zhou G, Chen T, Song Y, et al. (2006) Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 48: 1688-1697. (Pubitemid 44528172)
6. Fiordaliso F, Bianchi R, Staszewsky L, Cuccovillo I, Doni M, et al. (2004) Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol 37: 959-968. (Pubitemid 39446821)
7. Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115: 3213-3223. (Pubitemid 47012236)
8. Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121: 748-757.
9. Li D, Yang F, Cheng H, Liu C, Sun M, et al. (2013) Protective effects of total flavonoids from Flos Puerariae on retinal neuronal damage in diabetic mice. Mol Vis 19: 1999-2010.
10. Cai F, Chen X, Chen QJ, Ouyang CH, Zhang RX, et al. (2014) Orthogonal test design for optimizing the extraction of total flavonoids from Flos pueraria. Afr J Pharm Pharmacol 8: 1-8.
11. Yong R, Chen XM, Shen S, Vijayaraj S, Ma Q, et al. (2013) Plumbagin ameliorates diabetic nephropathy via interruption of pathways that include NOX4 signalling. PLoS One 8: e73428.
12. Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, et al. (2005) Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46: 4281-4287. (Pubitemid 44264633)
13. Reinking BE, Wedemeyer EW, Weiss RM, Segar JL, Scholz TD (2009) Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways. Cardiovasc Diabetol 8: 43.
14. Berry C, Brett M, Stevenson K, McMurray JJ, Norrie J (2008) Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart 94: 296-304. (Pubitemid 351303420)
15. Chavali V, Tyagi SC, Mishra PK (2013) Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes 6: 151-160.
16. Cai L, Kang YJ (2003) Cell death and diabetic cardiomyopathy. Cardiovasc Toxicol 3: 219-228. (Pubitemid 37296075)
17. Engel D, Peshock R, Armstong RC, Sivasubramanian N, Mann DL (2004) Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. Am J Physiol Heart Circ Physiol 287: H1303-H1311. (Pubitemid 39096680)
18. Li Z, Zhang T, Dai H, Liu G, Wang H, et al. (2007) Involvement of endoplasmic reticulum stress in myocardial apoptosis of streptozocin-induced diabetic rats. J Clin Biochem Nutr 41: 58-67. (Pubitemid 47266173)
19. Jie B, Zhang X, Wu X, Xin Y, Liu Y, et al. (2012) Neuregulin-1 suppresses cardiomyocyte apoptosis by activating PI3K/Akt and inhibiting mitochondrial permeability transition pore. Mol Cell Biochem 370: 35-43.
20. Yu W, Wu J, Cai F, Xiang J, Zha W, et al. (2012) Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. PLoS One 7: e52013.
21. Maisch B, Alter P, Pankuweit S (2011) Diabetic cardiomyopathy - fact or fiction? Herz 36: 102-115.
22. He K, Li X, Chen X, Ye X, Huang J, et al. (2011) Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice. J Ethnopharmacol 137: 1135-1142.
23. Lee KT, Sohn IC, Kim DH, Choi JW, Kwon SH, et al. (2000) Hypoglycemic and hypolipidemic effects of tectorigenin and kaikasaponin III in the streptozotocin-lnduced diabetic rat and their antioxidant activity in vitro. Arch Pharm Res 23: 461-466.
24. Bloomgarden ZT (2008) Glycemic control in diabetes: a tale of three studies. Diabetes Care 31: 1913-1919.
25. Miki T, Yuda S, Kouzu H, Miura T (2013) Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev 18: 149-166.
26. Rajamani U, Essop MF (2010) Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis. Am J Physiol Cell Physiol 299: C139-C147.
27. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107: 1058-1070.
28. Kuo WW, Wang WJ, Tsai CY, Way CL, Hsu HH, et al. (2013) Diallyl trisufide (DATS) suppresses high glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFkappaB signaling via attenuating ROS generation. Int J Cardiol 168: 270-280.
29. Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, et al. (2008) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 57: 460-469.
30. Soetikno V, Sari FR, Sukumaran V, Lakshmanan AP, Mito S, et al. (2012) Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway. Eur J Pharm Sci 47: 604-614.
31. Tsai KH, Wang WJ, Lin CW, Pai P, Lai TY, et al. (2012) NADPH oxidase-derived superoxide anion-induced apoptosis is mediated via the JNK-dependent activation of NF-kappaB in cardiomyocytes exposed to high glucose. J Cell Physiol 227: 1347-1357.
32. Rajesh M, Batkai S, Kechrid M, Mukhopadhyay P, Lee WS, et al. (2012) Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes 61: 716-727.
33. Lakshmanan AP, Harima M, Sukumaran V, Soetikno V, Thandavarayan RA, et al. (2012) Modulation of AT-1R/AMPK-MAPK cascade plays crucial role for the pathogenesis of diabetic cardiomyopathy in transgenic type 2 diabetic (Spontaneous Diabetic Torii) rats. Biochem Pharmacol 83: 653-660.
34. Li CJ, Lv L, Li H, Yu DM (2012) Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc Diabetol 11: 73.
35. Nakagami H, Morishita R, Yamamoto K, Yoshimura SI, Taniyama Y, et al. (2001) Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. Diabetes 50: 1472-1481. (Pubitemid 32500182)
36. Thandavarayan RA, Watanabe K, Ma M, Gurusamy N, Veeraveedu PT, et al. (2009) Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus. Am J Physiol Heart Circ Physiol 297: H911-H919.
37. Chang SH, Liu CJ, Kuo CH, Chen H, Lin WY, et al. (2011) Garlic Oil Alleviates MAPKs- and IL-6-mediated Diabetes-related Cardiac Hypertrophy in STZ-induced DM Rats. Evid Based Complement Alternat Med 2011: 950150.
38. Han T, Cheng G, Liu Y, Yang H, Hu YT, et al. (2012) In vitro evaluation of tectoridin, tectorigenin and tectorigenin sodium sulfonate on antioxidant properties. Food Chem Toxicol 50: 409-414.
39. Lee MK, Cho SY, Jang JY, Cho MS, Jeon SM, et al. (2001) Effects of Puerariae Flos and Puerariae Radix extracts on antioxidant enzymes in ethanol-treated rats. Am J Chin Med 29: 343-354.